Barclays' chief executive will undergo cancer treatment, the FTSE 100-listed lender said today. CS Venkatakrishnan, who will be treated for non-hodgkin lymphoma, said in a letter to colleagues that "doctors have advised that my prognosis is excellent, and my condition is curable with their prescribed regimen.
Full Story >>
Vote
+4